Thomas F. Ryan Jr - Nov 2, 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Nov 2, 2021
Transactions value $
$264,781
Form type
4
Date filed
11/4/2021, 05:45 PM
Previous filing
Aug 5, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $165K +1.29K +9.63% $128.18 14.6K Nov 2, 2021 Direct F1
transaction RGEN Common Stock Sale $388K +1.29K +10.66% $302.00 13.3K Nov 2, 2021 Direct F2
transaction RGEN Common Stock Sale -$288K -1K -7.5% $288.00 12.3K Nov 4, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +1.29K $0.00* 0 Nov 2, 2021 Common Stock 1.29K $128.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes three stock option exercises totaling 12,366 shares which were not previously included in the holder's beneficial ownership totals.
F2 $302.00 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.85 to $302.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 This option is currently exercisable